| Literature DB >> 29430463 |
Wen-Yu Cheng1, Huai-Jie Jia1, Xiao-Bing He1, Guo-Hua Chen1, Yuan Feng1, Chun-Yan Wang1, Xiao-Xia Wang2, Zhi-Zhong Jing1.
Abstract
Ectromelia virus (ECTV), the causative agent of mousepox, has emerged as a valuable model for investigating the host-Orthopoxvirus relationship as it relates to pathogenesis and the immune response. ECTV is a mouse-specific virus and causes high mortality in susceptible mice strains, including BALB/c and C3H, whereas C57BL/6 and 129 strains are resistant to the disease. To understand the host genetic factors in different mouse strains during the ECTV infection, we carried out a microarray analysis of spleen tissues derived from BALB/c and C57BL/6 mice, respectively, at 3 and 10 days after ECTV infection. Differential Expression of Genes (DEGs) analyses revealed distinct differences in the gene profiles of susceptible and resistant mice. The susceptible BALB/c mice generated more DEGs than the resistant C57BL/6 mice. Additionally, gene ontology and KEGG pathway analysis showed the DEGs of susceptible mice were involved in innate immunity, apoptosis, metabolism, and cancer-related pathways, while the DEGs of resistant mice were largely involved in MAPK signaling and leukocyte transendothelial migration. Furthermore, the BALB/c mice showed a strong induction of interferon-induced genes, which, however, were weaker in the C57BL/6 mice. Collectively, the differential transcriptome profiles of susceptible and resistant mouse strains with ECTV infection will be crucial for further uncovering the molecular mechanisms of the host-Orthopoxvirus interaction.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29430463 PMCID: PMC5752998 DOI: 10.1155/2017/6456180
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1(a) Spleen sections of the indicated mice at 10 dpi stained with H&E at 10 dpi. (b) The number of BALB/c and C57BL/6 mice exhibiting disease symptoms after ECTV infection. Five mice in each group were injected with 104 TCID50 of ECTV into the abdominal subcutaneous tissue. The status of infected mice was checked daily. (c) ECTV titers in spleen tissues of susceptible and resistant mice. Groups of BALB/c and C57BL/6 mice infected with ECTV were killed on the days indicated (3, 7, and 10 dpi). Viral titers in pooled spleen of each group were determined with three replications. ∗∗∗ means P < 0.001.
Total number of differentially expressed genes (DEGs)a.
| Mouse strain | BALB/c | C57BL/6 | ||
|---|---|---|---|---|
| After infection | 3 dpi | 10 dpi | 3 dpi | 10 dpi |
| Number of upregulated genes | 470 | 1453 | 123 | 540 |
| Number of downregulated genes | 273 | 731 | 238 | 1079 |
| Total number | 743 | 2184 | 361 | 1619 |
aMicroarray data of infected groups were normalized with uninfected group of each mouse strain. The DEGs were filtered using the criterion of cutoff limitation as a fold change ≥ 2 or ≤0.5.
List of 10 DEGs that were most up- or downregulated in BALB/c and C57BL/6 during ECTV infectionb.
| Mouse strain | BALB/c | C57BL/6 | ||||||
|---|---|---|---|---|---|---|---|---|
| After infection | 3 dpi versus uninfected | 10 dpi versus uninfected | 3 dpi versus uninfected | 10 dpi versus uninfected | ||||
| Gene category | Gene | Fold change | Gene | Fold change | Gene | Fold change | Gene | Fold change |
| Upregulated |
| 5.65 |
| 46.2 |
| 27.28 |
| 50.37 |
|
| 4.39 |
| 39.4 |
| 4.49 |
| 26.23 | |
|
| 4.32 |
| 24.2 |
| 3.13 |
| 22.26 | |
|
| 3.99 |
| 20.7 |
| 2.93 |
| 17.84 | |
|
| 3.95 |
| 17.9 |
| 2.81 |
| 15.25 | |
|
| 3.60 |
| 16.5 |
| 2.68 |
| 14.02 | |
|
| 3.57 |
| 14.0 |
| 2.59 |
| 10.06 | |
|
| 3.47 |
| 13.6 |
| 2.34 |
| 8.74 | |
|
| 3.42 |
| 13.6 |
| 2.32 |
| 7.71 | |
|
| 3.41 |
| 12.6 |
| 2.29 |
| 7.03 | |
|
| ||||||||
| Downregulated |
| 0.33 |
| 0.08 |
| 0.29 |
| 0.17 |
|
| 0.33 |
| 0.02 |
| 0.28 |
| 0.17 | |
|
| 0.32 |
| 0.03 |
| 0.28 |
| 0.17 | |
|
| 0.29 |
| 0.03 |
| 0.28 |
| 0.16 | |
|
| 0.28 |
| 0.03 |
| 0.27 |
| 0.16 | |
|
| 0.25 |
| 0.04 |
| 0.27 |
| 0.16 | |
|
| 0.25 |
| 0.05 |
| 0.26 |
| 0.15 | |
|
| 0.16 |
| 0.06 |
| 0.25 |
| 0.14 | |
|
| 0.08 |
| 0.02 |
| 0.25 |
| 0.13 | |
|
| 0.06 |
| 0.006 |
| 0.22 |
| 0.12 | |
bThe DEGs were ranked by fold change and those were the most (fold change) up- or downregulated in expression at 3 and 10 dpi in BALB/c and C57BL/6 mice.
Figure 2Analysis of common and unique gene expression differentials in two mouse strains at different times of postinfection. Venn diagrams of differentially expressed genes (DEGs) in BALB/c (a) and C57BL/6 (b) mice at 3 days and 10 days after infection (dpi). Venn diagrams of differentially expressed genes (DEGs) at 3 dpi (c) and 10 dpi (d) in two mouse strains.
The interferon-stimulated genes (ISGs) that were upregulated in BALB/c and C57BL/6 during ECTV infectionc.
| Genes | 3 dpi | 10 dpi | ||||
|---|---|---|---|---|---|---|
| Gene symbol | RefSeq | Gene name | Bi/Bu | Ci/Cu | Bi/Bu | Ci/Cu |
| OASL1 | AB067533 | 2′-5′-Oligoadenylate synthetase-like 1 | 1.91 | 0.82 | 3.34 | 1.21 |
| OAS2 | AB067535 | 2′-5′-Oligoadenylate synthetase 2 | 1.90 | 1.13 | 4.15 | 1.23 |
| IGTP | NM_018738 | Interferon gamma induced GTPase | 2.03 | 0.88 | 2.48 | 2.39 |
| IFI47 | NM_008330 | Interferon gamma inducible protein 47 | 2.07 | 0.81 | 2.60 | 1.66 |
| IFIT2 | NM_008332 | Interferon-induced protein with tetratricopeptide repeats 2 | 1.54 | 0.80 | 3.69 | 1.29 |
| IIGP1 | BM239828 | Interferon inducible GTPase 1 | 3.42 | 0.96 | 5.32 | 3.64 |
| IFI204 | NM_008329 | Interferon activated gene 204 | 1.52 | 0.85 | 6.10 | 2.16 |
| IFI202B | NM_011940 | Interferon activated gene 202B | 1.49 | 0.90 | 4.00 | 1.15 |
| IFI44 | BB329808 | Interferon-induced protein 44 | 2.49 | 0.89 | 4.93 | 2.42 |
| IFITM1 | BC027285 | Interferon induced transmembrane protein 1 | 1.03 | 0.95 | 2.10 | 1.36 |
| IFITM3 | BC010291 | Interferon induced transmembrane protein 3 | 1.09 | 1.13 | 1.73 | 1.49 |
| IFITM6 | BB193024 | Interferon induced transmembrane protein 6 | 1.18 | 1.15 | 1.92 | 1.86 |
| IFIH1 | AY075132 | Interferon induced with helicase C domain 1 | 1.57 | 1.17 | 1.82 | 1.42 |
| ISG15 | AK019325 | Interferon-stimulated protein (15 kda) | 1.73 | 1.22 | 1.93 | 0.92 |
| GBP1 | NM_010259 | Guanylate binding protein 1 | 4.32 | 0.86 | 6.60 | 17.84 |
| GBP2 | NM_010260 | Guanylate binding protein 2 | 3.60 | 0.82 | 7.15 | 3.28 |
| GBP3 | NM_018734 | Guanylate binding protein 3 | 1.82 | 0.98 | 3.27 | 2.l0 |
| GBP7 | BC010229 | Guanylate binding protein 7 | 2.39 | 1.04 | 3.61 | 2.44 |
| GBP8 | NM_029509 | Guanylate binding protein 8 | 1.69 | 1.21 | 2.24 | 3.20 |
| MX1 | M21039 | Myxovirus resistance 1 | 1.29 | 1.16 | 3.30 | 1.05 |
| EIF2 | AV328340 | Eukaryotic translation initiation factor 2- | 2.17 | 0.97 | 2.49 | 0.91 |
| CH25H | NM_009890 | Cholesterol 25-hydroxylase | 0.97 | 0.84 | 2.68 | 0.84 |
cThe interferon-stimulated genes (ISGs) differentially expressed in BALB/c and/or C57BL/6 were selected for analysis at 3 and 10 dpi. The capital “B” and “C” represent BALB/c and C57BL/6 mice, respectively. Superscripts “i” and “u” represent infected and uninfected mice, respectively.
The cytokines that were upregulated in BALB/c and C57BL/6 during ECTV infectiond.
| Genes | 3 dpi | 10 dpi | ||||
|---|---|---|---|---|---|---|
| Gene symbol | RefSeq | Gene name | Bi/Bu | Ci/Cu | Bi/Bu | Ci/Cu |
| IFN- | K00083 | Interferon gamma | 0.95 | 0.89 | 24.17 | 5.21 |
| IFN- | BF022827 | Interferon zeta | 0.44 | 2.34 | 0.89 | 1.00 |
| IFN- | NM_010503 | Interferon alpha 2 | 0.79 | 1.76 | 0.82 | 1.54 |
| GzmA | NM_010370 | Granzyme A | 0.68 | 1.83 | 1.13 | 5.51 |
| GzmB | NM_013542 | Granzyme B | 1.12 | 0.87 | 39.39 | 22.26 |
| GzmC | NM_010371 | Granzyme C | 0.92 | 0.89 | 5.96 | 0.96 |
| GzmD | NM_010372 | Granzyme D | 1.07 | 0.95 | 13.63 | 1.02 |
| GzmE | NM_010373 | Granzyme E | 1.33 | 0.98 | 10.21 | 1.07 |
| GzmF | NM_010374 | Granzyme F | 0.88 | 0.99 | 2.68 | 1.22 |
| GzmK | AB032200 | Granzyme K | 0.61 | 0.93 | 7.52 | 7.71 |
| KLRG1 | NM_016970 | Killer cell lectin-like receptor subfamily G, member 1 | 0.67 | 1.17 | 1.06 | 3.56 |
| KLRC1 | AF106008 | Killer cell lectin-like receptor subfamily C, member 1 | 1.19 | 0.67 | 5.57 | 1.89 |
| KLRK1 | AF039026 | Killer cell lectin-like receptor subfamily K, member 1 | 1.13 | 1.13 | 2.72 | 2.15 |
| CXCL1 | NM_008176 | Chemokine (C-X-C motif) ligand 1 | 2.43 | 1.16 | 7.16 | 1.99 |
| CXCL5 | NM_009141 | Chemokine (C-X-C motif) ligand 5 | 2.83 | 0.90 | 12.61 | 1.86 |
| CXCL9 | NM_008599 | Chemokine (C-X-C motif) ligand 9 | 1.45 | 1.07 | 3.99 | 2.86 |
| CXCL10 | NM_021274 | Chemokine (C-X-C motif) ligand 10 | 2.41 | 0.93 | 5.46 | 2.21 |
| CXCL11 | NM_019494 | Chemokine (C-X-C motif) ligand 11 | 1.47 | 1.11 | 5.19 | 1.07 |
| CCL2 | AF065933 | Chemokine (C-C motif) ligand 2 | 1.14 | 1.11 | 5.86 | 1.15 |
| CCL3 | NM_011337 | Chemokine (C-C motif) ligand 3 | 1.73 | 0.97 | 12.46 | 4.52 |
| CCL4 | AF128218 | Chemokine (C-C motif) ligand 4 | 0.85 | 1.23 | 4.65 | 2.72 |
| CCL6 | AV084904 | Chemokine (C-C motif) ligand 6 | 1.68 | 0.73 | 3.04 | 0.90 |
| CCL7 | AF128193 | Chemokine (C-C motif) ligand 7 | 0.98 | 0.95 | 3.34 | 1.79 |
| CCL8 | NM_021443 | Chemokine (C-C motif) ligand 8 | 0.85 | 1.26 | 4.16 | 4.29 |
| CCL12 | U50712 | Chemokine (C-C motif) ligand 12 | 1.08 | 1.35 | 4.81 | 1.41 |
| IL1- | BC003727 | Interleukin 1 alpha | 1.06 | 1.08 | 1.33 | 1.74 |
| IL1R2 | NM_010555 | Interleukin 1 receptor, type II | 1.45 | 0.89 | 8.99 | 1.99 |
| IL1F9 | AY071843 | Interleukin 1 family, member 9 | 1.23 | 1.90 | 0.77 | 1.71 |
| IL1RAP | NM_134103 | Interleukin 1 receptor accessory protein | 1.30 | 1.17 | 1.95 | 1.65 |
| IL1RN | M57525 | Interleukin 1 receptor antagonist | 1.17 | 0.75 | 2.73 | 1.06 |
| IL2R- | M28052 | Interleukin 2 receptor, | 1.11 | 0.56 | 2.64 | 0.95 |
| IL2R- | AF054581 | Interleukin 2 receptor, | 1.03 | 0.70 | 5.48 | 0.54 |
| IL12R- | NM_008353 | Interleukin 12 receptor, | 1.15 | 0.97 | 2.65 | 1.59 |
| IL33 | NM_133775 | Interleukin 33 | 1.05 | 0.84 | 3.83 | 0.81 |
| STAT1 | BB229853 | Signal transducer and activator of transcription 1 | 2.97 | 0.80 | 6.34 | 1.11 |
| STAT2 | AF088862 | Signal transducer and activator of transcription 2 | 1.77 | 1.01 | 2.04 | 1.60 |
| STAT3 | BG069527 | Signal transducer and activator of transcription 3 | 1.50 | 1.38 | 2.73 | 0.93 |
| TNFRSF9 | BC028507 | Tumor necrosis factor receptor superfamily, member 9 | 1.03 | 0.97 | 6.23 | 1.06 |
dThe cytokines differentially expressed in BALB/c and/or C57BL/6 were selected for analysis at 3 and 10 dpi. The capital “B” and “C” represent BALB/c and C57BL/6 mice, respectively. Superscripts “i” and “u” represent infected and uninfected mice, respectively.
Figure 3Verification of the gene expression by qRT-PCR. Nine differentially expressed genes (DEGs) containing up- or downregulated genes in microarray analysis at each time point (3 and 10 dpi) were selected randomly for validation of the RNA-seq data. Gene expression in ECTV-infected C57BL/6 (a) and BALB/c (b) mice using qRT-PCR was analyzed using the 2−ΔΔCt method.